LDL Receptor and ApoE Are Involved in the Clearance of ApoM-associated Sphingosine 1-Phosphate
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LDL Receptor and ApoE Are Involved in the Clearance of ApoM-associated Sphingosine 1-Phosphate
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 290, Issue 4, Pages 2477-2488
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2014-12-13
DOI
10.1074/jbc.m114.596445
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M
- (2013) Makoto Kurano et al. ATHEROSCLEROSIS
- Plasma Sphingosine-1-Phosphate Is Elevated in Obesity
- (2013) Greg M. Kowalski et al. PLoS One
- Targeting HDL-cholesterol to reduce residual cardiovascular risk
- (2012) Alma O. Iacob et al. CURRENT OPINION IN LIPIDOLOGY
- Modulation of lipid metabolism with the overexpression of NPC1L1 in mouse liver
- (2012) Makoto Kurano et al. JOURNAL OF LIPID RESEARCH
- The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles
- (2012) Christina Christoffersen et al. JOURNAL OF LIPID RESEARCH
- Apolipoprotein E Mediates Enhanced Plasma High-Density Lipoprotein Cholesterol Clearance by Low-Dose Streptococcal Serum Opacity Factor via Hepatic Low-Density Lipoprotein Receptors In Vivo
- (2011) Corina Rosales et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges
- (2011) Uchechukwu K. Sampson et al. Current Atherosclerosis Reports
- The Evolving Role of HDL in the Treatment of High-Risk Patients with Cardiovascular Disease
- (2011) H. Bryan Brewer JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease
- (2011) Kelley M Argraves et al. Lipids in Health and Disease
- LXR agonist increases apoE secretion from HepG2 spheroid, together with an increased production of VLDL and apoE-rich large HDL
- (2011) Makoto Kurano et al. Lipids in Health and Disease
- Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
- (2011) C. Christoffersen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus
- (2010) Paul J.W.H. Kappelle et al. ATHEROSCLEROSIS
- Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease
- (2010) Katherine J. E. Sattler et al. BASIC RESEARCH IN CARDIOLOGY
- Opposing Effects of Apolipoprotein M on Catabolism of Apolipoprotein B–Containing Lipoproteins and Atherosclerosis
- (2010) Christina Christoffersen et al. CIRCULATION RESEARCH
- Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters
- (2008) R. Ohkawa et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Plasma sphingosine 1-phosphate metabolism and analysis
- (2007) Yutaka Yatomi BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started